WDB Medical Data snaps up DZS Clinical, expanding services in Europe and Japan

Drugs and money
WDB Medical Data has acquired DZS Clinical Services, a provider of clinical development and data analytics services, for an undisclosed price. (Getty/LIgorko)

WDB Medical Data, a global CRO, acquired DZS Clinical Services, a provider of clinical development and data analytics services, for an undisclosed price.

The acquisition further expands WDBMD’s global presence with additional coverage in Europe and Japan, the company said. WDBMD is a U.S.-based subsidiary of WDB Holdings.

Financial terms of the deal weren’t disclosed; however, the DZS leadership team is expected to remain intact, WDB said.

Your Daily Newsletter — Free

Enjoying this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. To read on the go, sign up today to get biotech news and updates delivered right to your inbox!

“This acquisition and the addition of Greg Ambra and the DZS operations team complement our company and further our goal to provide even greater flexibility and affordability to more businesses and institutions worldwide,” Norifumi Ninokata, president and chief executive of WDBMD, said in a statement.

Ambra, president of DZS, added “access to WDBMD’s expertise and global resources will increase our capacity and allow us to offer a broader range of services to our clients.”